The bill amends several sections of the West Virginia Code concerning controlled substance schedules, specifically updating classifications for various drugs and substances. It introduces new substances to Schedule I, which includes a range of opiates, hallucinogens, and synthetic cannabinoids, while clarifying that fentanyl and carfentanil will remain classified as Schedule II substances. The bill also corrects existing errors in the code, ensuring that the legal language accurately reflects the current understanding of controlled substances and their associated risks.

Additionally, the bill outlines a comprehensive list of synthetic compounds and substances, including tryptamines, depressants, and stimulants, that will be classified under Schedules I through IV. It emphasizes the regulation of substances that act as Cannabinoid receptor type 1 agonists and introduces temporary listings for certain substances subject to emergency scheduling. Notably, it specifies that human chorionic gonadotropin is excluded from regulation when used in nonhuman species with FDA approval. The bill is set to take effect 90 days after passage, ensuring timely implementation of the updated regulations.

Statutes affected:
Introduced Version: 60A-2-204, 60A-2-206, 60A-2-208, 60A-2-210, 60A-2-212
Engrossed Version: 60A-2-204, 60A-2-206, 60A-2-208, 60A-2-210, 60A-2-212
Enrolled Version: 60A-2-204, 60A-2-206, 60A-2-208, 60A-2-210, 60A-2-212